Noteworthy

Jun 23, 2018
Realistic, multisensory training devices can contribute to a drug’s reception in the eyes of both patients and healthcare practitioners, writes Paul Sullivan.
Jun 22, 2018
Josh Reisberg outlines the foundation of a broad defense strategy for generic companies embroiled in Hatch-Waxman litigations.
Jun 21, 2018
China's nurse educator program aims to improve quality of care and make life simpler for physicians handling high patient load. Sebastian Bather reports.
Jun 20, 2018
Pharmaceutical Executive
Azar and Gottlieb out front in revising rebates, restructuring Medicare, and promoting competition. Jill Wechsler reports.
Jun 19, 2018
On May 1, China eliminated the tariff on 28 categories of imported drugs. Jin Zhang looks at the implications for foreign and domestic pharma companies.
Jun 18, 2018
Pharmaceutical Executive
Exploring new character benchmarks for today’s pharma executives, and whether they have the transformational traits to lead through change.
Jun 18, 2018
Pharmaceutical Executive
Weighing the crossover effect of US’s new pricing blueprint. 
Jun 11, 2018
Pharmaceutical Executive
Laboratory testing has become a critical access point for sales teams in the age of personalized medicine, writes Melissa Leonhauser.
May 22, 2018
Pharmaceutical Executive
In its 12th annual feature, Pharm Exec profiles a new round of biopharma products that are making waves in five key areas in healthcare and R&D.
May 14, 2018
Ellen Coleman outlines the highlights of a recent webinar on ensuring that patient advocacy is a key element of a market access strategy.
native1_300x100
lorem ipsum